Biktarvy, formally known as bictegravir, is a potent single-tablet therapy for controlling HIV infection. This drug integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to replicate within the body, significantly decreasing the viral burden. For many indivi